Frequently asked questions

You may have questions about your cancer diagnosis

When you meet with your healthcare provider, it’s important that you discuss any concerns or questions you may have about your disease and your treatment for it.
Below are some common ones that tend to come up. If you have additional questions, it’s a good idea to write them down in your treatment journal.

How is BRAFTOVI + MEKTOVI thought to work?

BRAFTOVI and MEKTOVI work together to help block signals that can cause melanoma cells with a BRAF mutation to grow out of control.

How long do I take BRAFTOVI + MEKTOVI?

It’s important to take BRAFTOVI + MEKTOVI for as long as your healthcare provider tells you. Don’t change your dose or stop your treatment unless your healthcare provider tells you to.

Do I need to take every dose of BRAFTOVI or MEKTOVI?

Take BRAFTOVI + MEKTOVI exactly as your healthcare provider tells you. Don’t change your dose unless your healthcare provider tells you to.

What if I miss a dose?

If you miss a dose of BRAFTOVI: Take it as soon as you remember. But if it is within 12 hours of your next scheduled dose, just take your next dose at your regular time. Do not make up for the missed dose. Do not take an extra dose if you vomit after taking your scheduled dose. Take your next dose at a regular time.

If you miss a dose of MEKTOVI: Take it as soon as you remember. But if it is within 6 hours of your next scheduled dose, just take your next dose at your regular time. Do not make up for the missed dose. Do not take an extra dose if you vomit after taking your scheduled dose. Take your next dose at your regular time.

Please find more information on Taking BRAFTOVI + MEKTOVI here.

What can I do about side effects?

Be sure to tell your healthcare provider if you have any side effects. In addition, tell your healthcare provider about all the medicines you take, including prescription and over-the-counter medicines, vitamins, and herbal supplements. BRAFTOVI + MEKTOVI and certain other medicines can affect one another, causing side effects or affecting how BRAFTOVI + MEKTOVI or the other medicines work. Avoid grapefruit during treatment with BRAFTOVI. Grapefruit products may increase the amount of BRAFTOVI in your body.

Can I take BRAFTOVI + MEKTOVI with meals?

BRAFTOVI + MEKTOVI can be taken with or without food. Avoid grapefruit during treatment with BRAFTOVI. Grapefruit products may increase the amount of BRAFTOVI in your body.

Does BRAFTOVI + MEKTOVI have to be refrigerated?

BRAFTOVI + MEKTOVI can be stored at room temperature, so there’s no need to keep it in the fridge. Store at 68°F to 77°F.

Discuss your disease and treatment with your healthcare provider

DOWNLOAD THE DISCUSSION GUIDE

Take information about BRAFTOVI + MEKTOVI on the go

DOWNLOAD THE PATIENT BROCHURE

BRAFTOVI + MEKTOVI video library

Explore these video resources to learn about dosing and administration, our text message support programs, and more

Caregiver Text Message Program

Caregiver Video

Dosing and Administration

Patient Text Message Program

Meet the Scientist

Glossary of terms

Advanced melanoma (mel-uh-NO-muh)

When melanoma moves from where it started to other parts of the body, it is referred to as advanced. This is also called stage IV cancer. If the melanoma has spread to parts of the body that are farther away from the original site, it is referred to as metastatic, or stage IV disease."

BRAF gene (BEE-raf jeen)

Normally, the BRAF gene makes the BRAF protein, which helps send signals within a cell. When the BRAF gene has a mutation, the signaling of the BRAF protein can increase. This may cause melanoma cells to grow out of control. BRAFTOVI and MEKTOVI work together to help block signals that can cause your melanoma cells to grow out of control.

Chemotherapy (key-mo-THER-uh-pee)

Also called chemo, chemotherapy is a form of treatment that is given a number of ways, including via an intravenous injection (IV) or taken in a pill. It is given by itself or with radiation or surgery. Chemotherapy attacks any quickly dividing cell in the body—normal or cancerous. Chemotherapy is often given to patients whose cancer has spread or has come back, or when there’s a strong chance that it might return.

Clinical trial (KLIN-i-kuhl trahyl)

Clinical trials are scientifically controlled research studies that determine if a medicine is safe and effective for patients. Successful clinical trials are required in order to gain regulatory approval for new medications.

Complete response

A response to treatment that results in the disappearance of all signs of cancer. This is also called complete remission, and does not always mean the cancer has been cured.

Immunotherapy (im-yuh-no-THER-uh-pee)

Cancer treatment that uses the body’s own immune system to fight cancer is called immunotherapy. With immunotherapy, a cancer patient is given a treatment that boosts his or her own immune system.

Median (MEE-dee-un)

Median is a statistics term that means the middle value in a set of measurements.

Metastatic (meh-tuh-STAT-ick)

Cancer cells that have spread beyond the original site, also called the primary site, are called metastatic. Cancer cells will often spread in the bloodstream or the lymph system. Cancer that has spread close to the primary site is called regional or local metastasis. A distant metastasis is farther way, such as when melanoma spreads to the brain.

Mutation (mew-TAY-shun)

All cancer is caused when a single cell in a person’s body changes, or mutates, in a harmful way. That cell then multiplies, creating new cancer-causing cells. Some mutations are genetic, meaning they are passed on from parent to child. Others, like BRAF-mutation melanoma, are not genetic and happen after birth.

Overall response rate

Overall response rate is the percentage of patients whose cancer shrinks or disappears after treatment.

Partial response

A response to treatment that results in a decrease in the extent of cancer in the body. This is also called partial remission.

Progression-free survival (pruh-GREH-shun)

The length of time during and after the treatment of a disease, such as cancer, that a patient lives with the disease but it does not get worse. In a clinical trial, measuring the progression-free survival is one way to see how well a new treatment works. Also called PFS.

About Array BioPharma

Founded on science, focused on patients.

Array BioPharma Inc. is a biopharmaceutical company focused on the discovery, development, and delivery of targeted small-molecule cancer drugs, including BRAFTOVI + MEKTOVI. Founded in 1998 and headquartered in Boulder, Colorado, Array BioPharma has a portfolio of oncology molecules in various stages of development.

For over 20 years, Array BioPharma has been fully dedicated to improving the lives of those living with cancer. And this is just the beginning.

Meet one of the scientists at Array BioPharma

Important Safety
Information and Indication

What is the most important information I should know about BRAFTOVI?

BRAFTOVI may cause serious side effects, including:

  • Risk of new skin cancers. BRAFTOVI, when used alone or with MEKTOVI, may cause skin cancers called cutaneous squamous cell carcinoma or basal cell carcinoma
  • Talk to your healthcare provider about your risk for these cancers

    Check your skin and tell your healthcare provider right away about any skin changes, including a new wart, skin sore or reddish bump that bleeds or does not heal, or change in size or color of a mole

    Your healthcare provider should check your skin before and during treatment, and for up to 6 months after you stop treatment to look for any new skin cancers

    Your healthcare provider should also check for cancers that may not occur on the skin. Tell your healthcare provider about any new symptoms that develop during treatment

  • Bleeding problems. BRAFTOVI, when taken with MEKTOVI, can cause serious bleeding problems, including in your stomach or brain, that can lead to death. Call your healthcare provider and get medical help right away if you have any signs of bleeding, including: headaches, dizziness, or feeling weak; cough up blood or blood clots; vomit blood or your vomit looks like “coffee grounds”; red or black stools that look like tar
  • Eye problems. Tell your healthcare provider right away if you develop any of these symptoms of eye problems: blurred vision, loss of vision, or other vision changes; see colored dots; see halos (blurred outline around objects); eye pain, swelling, or redness
  • Changes in the electrical activity of your heart called QT prolongation. QT prolongation can cause irregular heartbeats that can be life-threatening. Your healthcare provider should do tests before you start and during your treatment to check your body salts (electrolytes). Tell your healthcare provider right away if you feel faint, light-headed, dizzy, or if you feel your heart beating irregularly or fast

MEKTOVI may cause serious side effects, including:

  • Heart problems, including heart failure. Your healthcare provider should check your heart function before and during treatment. Call your healthcare provider right away if you have any of the following signs and symptoms of a heart problem: feeling like your heart is pounding or racing; shortness of breath; swelling of your ankles and feet; feeling light-headed
  • Blood clots. MEKTOVI can cause blood clots in your arms or legs, which can travel to your lungs and can lead to death. Get medical help right away if you have the following symptoms: chest pain; sudden shortness of breath or trouble breathing; pain in your legs with or without swelling; swelling in your arms and legs; a cool, pale arm or leg
  • Eye problems. MEKTOVI can cause serious eye problems that might lead to blindness. Call your healthcare provider right away if you develop any of these symptoms of eye problems: blurred vision, loss of vision, or other vision changes; see colored dots; see halos (blurred outline around objects); eye pain, swelling, or redness
  • Lung or breathing problems. MEKTOVI can cause lung or breathing problems. Tell your healthcare provider if you have any new or worsening symptoms of lung or breathing problems, including: shortness of breath; cough
  • Liver problems. Your healthcare provider should perform blood tests to check your liver function before and during treatment. Tell your healthcare provider if you have any of the following signs and symptoms of a liver problem: yellowing of your skin or the white part of your eyes (jaundice); dark or brown (tea-colored) urine; nausea or vomiting; loss of appetite
  • Muscle problems (rhabdomyolysis). MEKTOVI can cause muscle problems that can be severe. Your healthcare provider should perform a blood test to check your levels of an enzyme in your blood called creatine phosphokinase (CPK) before and during treatment. Tell your healthcare provider right away if you develop any of these symptoms: weakness; muscle aches or pain; dark, reddish urine
  • Bleeding problems. MEKTOVI, when taken with BRAFTOVI, can cause serious bleeding problems, including in your brain or stomach, that can lead to death. Call your healthcare provider and get medical help right away if you have any signs of bleeding, including: headaches, dizziness, or feeling weak; cough up blood or blood clots; vomit blood or your vomit looks like “coffee grounds”; red or black stools that look like tar

The most common side effects of BRAFTOVI and MEKTOVI when taken in combination: fatigue, nausea, diarrhea, vomiting, pain or swelling of your joints, abdominal pain BRAFTOVI may cause fertility problems in males. Talk to your healthcare provider if this is a concern for you.

These are not all the possible side effects of BRAFTOVI and MEKTOVI.

Call your doctor for medical advice about side effects. You may report side effects to FDA at 1-800-FDA-1088. You may also report side effects to Array BioPharma Inc. at 1-844-792-7729.

Before taking BRAFTOVI + MEKTOVI, tell your healthcare provider about all of your medical conditions, including if you:

  • have had bleeding problems
  • have eye problems
  • have heart problems, including a condition called long QT syndrome
  • have been told that you have low blood levels of potassium, calcium, or magnesium
  • have liver or kidney problems
  • have had blood clots
  • have lung or breathing problems
  • have any muscle problems
  • have high blood pressure (hypertension)
  • are pregnant or plan to become pregnant. BRAFTOVI + MEKTOVI can harm your unborn baby.
    • Females who are able to become pregnant should use effective nonhormonal birth control (contraception) during treatment and for at least 30 days after the final dose. Birth control methods that contain hormones (such as birth control pills, injections, or transdermal systems) may not work as well during treatment with BRAFTOVI
    • Tell your healthcare provider right away if you become pregnant or think you might be pregnant during treatment with BRAFTOVI + MEKTOVI
  • are breastfeeding or plan to breastfeed. Do not breastfeed during treatment and for 2 weeks after the final dose. Talk to your healthcare provider about the best way to feed your baby during this time

Tell your healthcare provider about all the medicines you take, including prescription and over-the-counter medicines, vitamins, and herbal supplements.

BRAFTOVI and certain other medicines can affect each other, causing side effects or affecting how BRAFTOVI or other medicines work. You should also avoid grapefruit products during treatment with BRAFTOVI.

Please see both full BRAFTOVI Prescribing Information, including Medication Guide, and full MEKTOVI Prescribing Information, including Patient Information for additional information.

What is BRAFTOVI + MEKTOVI?

BRAFTOVI and MEKTOVI are prescription medicines used together to treat people with a type of skin cancer called melanoma:

  • that has spread to other parts of the body or cannot be removed by surgery, and
  • that has a certain type of abnormal “BRAF” gene

BRAFTOVI should not be used to treat people with wild-type BRAF melanoma. Your healthcare provider will perform a test to make sure that BRAFTOVI + MEKTOVI is right for you. It is not known if BRAFTOVI or MEKTOVI is safe and effective in children.

Important Safety
Information and Indication

What is the most important information I should know about BRAFTOVI?

BRAFTOVI may cause serious side effects, including:

  • Risk of new skin cancers. BRAFTOVI, when used alone or with MEKTOVI, may cause skin cancers called cutaneous squamous cell carcinoma or basal cell carcinoma
  • Talk to your healthcare provider about your risk for these cancers

    Check your skin and tell your healthcare provider right away about any skin changes, including a new wart, skin sore or reddish bump that bleeds or does not heal, or change in size or color of a mole

    Your healthcare provider should check your skin before and during treatment, and for up to 6 months after you stop treatment to look for any new skin cancers

    Your healthcare provider should also check for cancers that may not occur on the skin. Tell your healthcare provider about any new symptoms that develop during treatment

  • Bleeding problems. BRAFTOVI, when taken with MEKTOVI, can cause serious bleeding problems, including in your stomach or brain, that can lead to death. Call your healthcare provider and get medical help right away if you have any signs of bleeding, including: headaches, dizziness, or feeling weak; cough up blood or blood clots; vomit blood or your vomit looks like “coffee grounds”; red or black stools that look like tar
  • Eye problems. Tell your healthcare provider right away if you develop any of these symptoms of eye problems: blurred vision, loss of vision, or other vision changes; see colored dots; see halos (blurred outline around objects); eye pain, swelling, or redness
  • Changes in the electrical activity of your heart called QT prolongation. QT prolongation can cause irregular heartbeats that can be life-threatening. Your healthcare provider should do tests before you start and during your treatment to check your body salts (electrolytes). Tell your healthcare provider right away if you feel faint, light-headed, dizzy, or if you feel your heart beating irregularly or fast

MEKTOVI may cause serious side effects, including:

  • Heart problems, including heart failure. Your healthcare provider should check your heart function before and during treatment. Call your healthcare provider right away if you have any of the following signs and symptoms of a heart problem: feeling like your heart is pounding or racing; shortness of breath; swelling of your ankles and feet; feeling light-headed
  • Blood clots. MEKTOVI can cause blood clots in your arms or legs, which can travel to your lungs and can lead to death. Get medical help right away if you have the following symptoms: chest pain; sudden shortness of breath or trouble breathing; pain in your legs with or without swelling; swelling in your arms and legs; a cool, pale arm or leg
  • Eye problems. MEKTOVI can cause serious eye problems that might lead to blindness. Call your healthcare provider right away if you develop any of these symptoms of eye problems: blurred vision, loss of vision, or other vision changes; see colored dots; see halos (blurred outline around objects); eye pain, swelling, or redness
  • Lung or breathing problems. MEKTOVI can cause lung or breathing problems. Tell your healthcare provider if you have any new or worsening symptoms of lung or breathing problems, including: shortness of breath; cough
  • Liver problems. Your healthcare provider should perform blood tests to check your liver function before and during treatment. Tell your healthcare provider if you have any of the following signs and symptoms of a liver problem: yellowing of your skin or the white part of your eyes (jaundice); dark or brown (tea-colored) urine; nausea or vomiting; loss of appetite
  • Muscle problems (rhabdomyolysis). MEKTOVI can cause muscle problems that can be severe. Your healthcare provider should perform a blood test to check your levels of an enzyme in your blood called creatine phosphokinase (CPK) before and during treatment. Tell your healthcare provider right away if you develop any of these symptoms: weakness; muscle aches or pain; dark, reddish urine
  • Bleeding problems. MEKTOVI, when taken with BRAFTOVI, can cause serious bleeding problems, including in your brain or stomach, that can lead to death. Call your healthcare provider and get medical help right away if you have any signs of bleeding, including: headaches, dizziness, or feeling weak; cough up blood or blood clots; vomit blood or your vomit looks like “coffee grounds”; red or black stools that look like tar

The most common side effects of BRAFTOVI and MEKTOVI when taken in combination: fatigue, nausea, diarrhea, vomiting, pain or swelling of your joints, abdominal pain BRAFTOVI may cause fertility problems in males. Talk to your healthcare provider if this is a concern for you.

These are not all the possible side effects of BRAFTOVI and MEKTOVI.

Call your doctor for medical advice about side effects. You may report side effects to FDA at 1-800-FDA-1088. You may also report side effects to Array BioPharma Inc. at 1-844-792-7729.

Before taking BRAFTOVI + MEKTOVI, tell your healthcare provider about all of your medical conditions, including if you:

  • have had bleeding problems
  • have eye problems
  • have heart problems, including a condition called long QT syndrome
  • have been told that you have low blood levels of potassium, calcium, or magnesium
  • have liver or kidney problems
  • have had blood clots
  • have lung or breathing problems
  • have any muscle problems
  • have high blood pressure (hypertension)
  • are pregnant or plan to become pregnant. BRAFTOVI + MEKTOVI can harm your unborn baby.
    • Females who are able to become pregnant should use effective nonhormonal birth control (contraception) during treatment and for at least 30 days after the final dose. Birth control methods that contain hormones (such as birth control pills, injections, or transdermal systems) may not work as well during treatment with BRAFTOVI
    • Tell your healthcare provider right away if you become pregnant or think you might be pregnant during treatment with BRAFTOVI + MEKTOVI
  • are breastfeeding or plan to breastfeed. Do not breastfeed during treatment and for 2 weeks after the final dose. Talk to your healthcare provider about the best way to feed your baby during this time

Tell your healthcare provider about all the medicines you take, including prescription and over-the-counter medicines, vitamins, and herbal supplements.

BRAFTOVI and certain other medicines can affect each other, causing side effects or affecting how BRAFTOVI or other medicines work. You should also avoid grapefruit products during treatment with BRAFTOVI.

Please see both full BRAFTOVI Prescribing Information, including Medication Guide, and full MEKTOVI Prescribing Information, including Patient Information for additional information.

What is BRAFTOVI + MEKTOVI?

BRAFTOVI and MEKTOVI are prescription medicines used together to treat people with a type of skin cancer called melanoma:

  • that has spread to other parts of the body or cannot be removed by surgery, and
  • that has a certain type of abnormal “BRAF” gene

BRAFTOVI should not be used to treat people with wild-type BRAF melanoma. Your healthcare provider will perform a test to make sure that BRAFTOVI + MEKTOVI is right for you. It is not known if BRAFTOVI or MEKTOVI is safe and effective in children.